Compounds > dihydroxyphenylalanine

dihydroxyphenylalanine and 3,4-dihydroxyphenylacetaldehyde

dihydroxyphenylalanine has been researched along with 3,4-dihydroxyphenylacetaldehyde in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alter, S; Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Miller, GW; Sharabi, Y; Strong, R; Sullivan, P1
Goldstein, DS; Holmes, C; Kopin, IJ; Mash, DC; Sharabi, Y; Sullivan, P1

Other Studies

2 other study(ies) available for dihydroxyphenylalanine and 3,4-dihydroxyphenylacetaldehyde

ArticleYear
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease.
    Journal of neurochemistry, 2013, Volume: 126, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase 1 Family; Aldehyde Dehydrogenase, Mitochondrial; Animals; Brain Chemistry; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Parkinson Disease; Putamen; Retinal Dehydrogenase; Vesicular Monoamine Transport Proteins

2013
Decreased vesicular storage and aldehyde dehydrogenase activity in multiple system atrophy.
    Parkinsonism & related disorders, 2015, Volume: 21, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aldehyde Dehydrogenase; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Frontal Lobe; Humans; Male; Methoxyhydroxyphenylglycol; Multiple System Atrophy; Neurons; Norepinephrine; Parkinson Disease

2015